reSee.it - Related Video Feed

The discussion centers on new evidence regarding myocarditis and pericarditis in the context of mRNA vaccination. It cites earlier 2022 German research showing that heart damage seen in myocarditis cases after vaccination may be a vaccine-triggered autoimmune reaction. The study analyzed endomyocardial biopsy samples and found that the cardiac tissue’s spike protein detection and CD4+ T cell–dominated inflammation suggested an autoimmune mechanism linking the vaccine to heart damage. This was contrasted with an Israel-based population study of hundreds of thousands of unvaccinated individuals that reported no increase in myocarditis or pericarditis incidence, highlighting a discrepancy with the vaccine-triggered autoimmune hypothesis. The center of the new claim is a study published in Circulation by the American Heart Association. The speakers emphasize the credibility of Circulation as a top cardiovascular journal. The study used an experimental mouse model to induce cardiac damage and then examined humans with similar heart damage after vaccination to see if the same mechanism applied. They report that T cells from patients with acute myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self-proteins. In other words, the immune cells targeting the spike protein may also attack cardiac proteins due to molecular similarity. Further details from the study indicate that, in patients with mild pericarditis after mRNA vaccination (but not in those with COVID-19), there was an expanded pattern of cytokine production similar to that observed in myopericarditis–affected mice and in autoimmune myocarditis. The takeaway provided in plain language is that post-mRNA vaccine myopericarditis is driven by molecular mimicry, causing the immune system to fail to distinguish self from non-self in susceptible patients. The susceptibility is described as being influenced by the widespread distribution of the vaccine, which purportedly leads to heart-homing imprinting and a heart-targeted autoimmune response. The speakers stress that this journal is not fringe and highlight its high impact in cardiovascular medicine. They conclude that the data collectively suggest a mechanism by which the vaccine could provoke cardiac autoimmunity, with implications for clinical communication and understanding of post-vaccination myocarditis.

モデルナの配列は大腸菌で利用するビクター配列だが、ファイザーの配列にはSV40の配列の一部が含まれている。SV40は遺伝子の発現を上昇させるプロモーターだが、発がん性を持つウイルスとしても知られている。mRNAワクチン製造には全く不要な配列であり、なぜこのような配列があるのかが問題である。この配列があるとDNAが移行しやすくなり、ゲノムに入りやすくなる。SV40のプロモーターの中には核に移行する配列も入っている。試験管内でmRNAを合成するプロセスに全く関係ないSV40のプロモーター配列がなぜ残されているのかが疑問視されている。実験室ではよく使われるSV40プロモーターが、なぜmRNAワクチンに入っているのかが問題である。 **Translation:** Moderna's sequence uses a vector sequence common in E. coli, but Pfizer's sequence contains a portion of the SV40 sequence. SV40 is a promoter that increases gene expression but is also known as a carcinogenic virus. This sequence is completely unnecessary for mRNA vaccine production, and the question is why such a sequence is present. This sequence makes DNA more likely to migrate and enter the genome. The SV40 promoter also contains a sequence that migrates to the nucleus. The question is why the SV40 promoter sequence, which is completely unrelated to the process of synthesizing mRNA in vitro, remains. The SV40 promoter, which is often used in laboratories, is questioned as to why it is included in the mRNA vaccine.

The discussion centers on evidence linking myocarditis and pericarditis to mRNA vaccination and the proposed mechanism behind it. It references a 2022 German study reporting that endomyocardial biopsy data from people with myocarditis showed cardiac detection of the spike protein and CD4+ T cell–dominated inflammation, suggesting a vaccine-triggered autoimmune reaction. The presenters note headlines at the time comparing myocarditis risk to infection, with claims that infection causes more myocarditis, and remind that vaccines were said not to stop transmission. They then cite a large Israeli population study from the same year involving subjects not vaccinated against SARS-CoV-2, which found no increase in the incidence of myocarditis or pericarditis, implying no observed vaccine-related signal in that cohort. Attention shifts to a more recent study published in Circulation by the American Heart Association, described as a high-impact, non-fringe journal, indicating a clearer mechanism has been demonstrated. The study described used an experimental mouse model to induce cardiac damage and then compared it to human cases with heart damage following vaccination. It states that T cells from patients with acute myocarditis or myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, meaning the immune response to the spike protein can cross-react with heart tissues. The researchers further report that functional responses to potassium channels in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19, showed an expanded pattern of cytokine production similar to that observed in myopericarditis mice and in autoimmune myocarditis. In plain terms, the summary of their takeaway is that post-mRNA vaccine myopericarditis is driven by molecular mimicry: the immune system cannot distinguish self from non-self, leading to an autoimmune attack on heart tissue in susceptible patients. The distribution of the vaccine (its widespread dissemination) is cited as a factor that makes patients susceptible by promoting heart-homing imprinting, effectively creating an anti-heart autoimmune response. The speakers emphasize that this Circulation article is a top-tier source, underscoring that the mechanism has been demonstrated with both animal models and human pathology, supporting the claim that the phenomenon has a defined immunological basis.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

The symposium revolves around the science and safety implications of Replicating/Replicon vaccines and broader RNA vaccine platforms, with a sequence of expert presentations and reactions from the panel. -荒川博 presents the central premise that Replicon vaccines (replicating or self-amplifying RNA vaccines) raise unique safety and biosafety concerns beyond traditional mRNA vaccines. He frames the discussion around the idea that these vaccines “increase and mutate” within the host, potentially evolving in ways that could affect humans and populations. He references specific real-world events and case observations, including severe vascular events and tissue damage in some vaccine recipients, as motivation to scrutinize this technology carefully. -荒川 emphasizes that Replicon vaccines differ from conventional mRNA vaccines by embedding replicative machinery so that the RNA self-amplifies inside cells. He explains that, unlike ordinary mRNA vaccines, replication can produce more copies of the RNA and additional viral proteins, potentially leading to unexpected immune and biological consequences. He notes that the Alpha virus replicase used in some designs is designed to enable replication and increased antigen production, but that high mutation and recombination potential could yield variants or new properties. -藤本、藤田（参加者は複数） and others discuss the science of replication in viruses, highlighting the Central Dogma nuances. They describe that normally DNA → RNA → protein is the standard flow, but some viruses (RNA viruses and certain retroviruses) can reverse or bypass parts of this flow (RNA to DNA in retroviruses; RNA to RNA replication in some RNA viruses). This provides a conceptual basis for why replicating vaccines could, in principle, generate abnormal replication dynamics or new variants. -コロナウイルスRNAワクチンの議論では、Repliconの増殖と変異率の高さ、組換えの可能性、体内拡散の可能性を挙げて、「増えると変わる」性質が人の体内でどう影響するかが核心テーマとして挙げられます。アルファウイルス由来のレプリカーゼを使う場合、修復機能が不完全なRNAの増殖過程で、予想外の抗原変異を引き起こすリスクがあるとの指摘が出てきます。 -リスクの具体例として、ウイルスの殻（エンベロープ）とエクソソームを介した分布、自己拡散型ワクチンによる体内の遺伝子素材の取り込み、さらには他の人へ感染・伝播するアウトブレークの可能性、という仮説的懸念が提示されます。レプリコンワクチンは「空の遺伝子を抗原遺伝子に置き換えた陰性空間を持つウイルス」という説明が繰り返され、組換え・遺伝子交換・逆転など、従来のDNA・RNA動態の外に出る事象が起こり得ると議論されます。 -一部のスピーカーは、日本での試験・臨床・規制の動きを取り上げ、FDA/国内基準値を超えるDNA混入、SV40プロモーター混入の報告など、製品レベルでの懸念を指摘します。ケビン・マッカーシー氏の分析紹介では、日本市場で使われているファイザー社のコロナワクチンにDNA混入の痕跡があったこと、SV40プロモーター混入の可能性が指摘され、脂質ナノ粒子を通じた細胞内へのDNA／エクソンの取り込みリスクが懸念事項として挙げられます。これにより、RNAワクチンのフォーマットが終わるのではなく、プラットフォーム自体が拡大・進化する過程で新たなリスクを生む可能性を示唆します。 -IGG4関連疾患の急増とコロナワクチンの関連を例示する報告を紹介。IGG-4抗体が高値となり、多様な臓器炎症を引き起こす病態が観察され、ウイルス感染・ワクチン接種と免疫抑制・過剰免疫の連携が臨床で見られるケースの存在が議論されました。これにより、免疫の過剰反応・異常免疫を招く可能性があるとの懸念が示唆されました。 -ウイルス学・免疫学の専門家は、Repliconワクチンの「増殖・変異・組換えの三拍子」が、長期的・広範な公衆衛生影響をもたらし得る点を強調します。従来のウイルスワクチンの枠組みを超え、自己拡散・他者伝播・遺伝子汚染の可能性を定量的に評価する必要があると主張します。 -議論は、Repliconの潜在的リスクと実利を天秤にかけるもので、現時点で「安全」と断定できないという結論に至る場面が多くありました。実臨床での結果を長期観察で検証し、エビデンスに基づく判断を求める声が複数の speaker から出ました。 -最後に、メディア・一般市民への啓蒙の喚起と、透明性の高い情報提供、そして次世代ワクチン開発の安全性を担保するための厳格な規制・評価の重要性が強調されました。現状の科学的理解には限界があり、今後も公衆衛生への影響を見据えた厳密な検証が不可欠であるとの結論が共有されました。 overall, the event centers on the scientific basis, potential risks, and regulatory considerations of Replicon vaccines, contrasted with traditional mRNA vaccines, with emphasis on mutation, recombination, potential horizontal spread, DNA contamination concerns, immune dysregulation (including IGG4-associated phenomena), and the need for rigorous, transparent evaluation before broad deployment.

The speaker presents findings that show the spike protein, present in COVID-19 vaccines, is produced not only in the deltoid muscles where the vaccine is injected, but also in various organs. They provide examples of a 28-year-old man and an elderly man, both showing strong expression of the spike protein in the testes. The images reveal a decrease in spermatocytes and an increase in spike protein expression in the testicular tissue. The speaker concludes with a personal comment, expressing their disturbance by the images shown.

A cardiologist provides an update on the Pfizer and Moderna vaccines. Studies have shown that the vaccines can cause direct harm to heart muscle cells, abnormal heart contractions, and abnormal electrical activity. Messenger RNA from the vaccines has been found in the human heart and circulating in the blood for up to 28 days. The spike protein produced by the messenger RNA has also been detected in the blood for up to 6 months. The spike protein is dangerous to cells, tissues, and organs in the body. The messenger RNA used in the vaccines has been modified and is synthetic. Autopsy studies have shown that the vaccine can cause myocarditis and cardiac damage. A basketball player who received the vaccine suffered a cardiac arrest and died two years later.

mRNAワクチンを接種した妊婦から生まれた子供の血中に異常なタンパク質構造アミロイド用繊維が確認されたとする研究結果が発表された。日本では、防疫対策など社会システム問題の抜本的解決が急務となっている。自給自立国家モデル都市では日本復活の志を共にする人を募っている。 自給自立国家モデル都市の道徳教育内容では、子供たちに「お天道様が見ているから悪いことをしてはいけない」という日本の伝統的な倫理観を伝え、一人一人の心に神観、倫理観を育む。日本は神を愛する心で和の心を培い歴史を築いてきた。モデル都市では、子供たちが生きがいを持ち、日本の未来を担えるよう、お天道様や神様の存在、愛情主義について科学的、論理的に教育する。その教材はホームページで公開されている。 **Translation:** Research suggests that children born to pregnant women who received mRNA vaccines have abnormal protein structures, amyloid-like fibrils, in their blood. In Japan, fundamental solutions to social system problems such as epidemic prevention measures are urgently needed. The self-sufficient national model city is looking for people who share the desire to revive Japan. The moral education content of the self-sufficient national model city conveys the traditional Japanese ethics of "Don't do bad things because the sun is watching" to children, fostering a sense of God and ethics in each individual's heart. Japan has cultivated a spirit of harmony and built its history with a heart that loves God. In the model city, children are scientifically and logically educated about the existence of the sun and God, and about altruism, so that they can have a purpose in life and be responsible for the future of Japan. The teaching materials are available on the website.

先生方のプロフィールを紹介します。コマ野先生は薬学博士であり、100年生き方塾の代表理事を務めています。最近の研究では、コロナワクチン接種後に認知症リスクが増加する可能性が示されています。65歳以上の人々に対する調査では、ワクチン接種者の認知症リスクが未接種者と比べて2倍に増加しました。この結果は、認知症の増加と関連がある可能性が指摘されています。この情報は重要であり、認知症の予防について考える上で重要な示唆を与えています。 Translation: Let me introduce the profiles of our guest speakers. Dr. Komanoya is a pharmaceutical doctor and the representative director of the 100-Year Life Academy. Recent research suggests an increased risk of dementia after receiving the corona vaccine. A study on people aged 65 and above found that the risk of dementia for vaccine recipients doubled compared to non-recipients. This indicates a potential link between vaccine and dementia risk, providing crucial insights for dementia prevention.

The spike protein, according to research in South Africa, induces fibrin from fibrinogen, forming the backbone of clotting in a way not previously seen. Unlike normal fibrin clots that are easily broken down, clots formed from COVID or the spike protein from the vaccine are difficult to break down, causing issues for many people. A cardiologist stated that in their decades of practice, they have never treated as many blood clots as in the last five years. These blood clots occur after the virus infection and the vaccine because the spike protein causes blood clots. Therefore, it is reckless to continue vaccinating people and loading the body with spike protein, causing more blood clots. According to a paper in Cell (July 2021), the nucleoprotein, not the spike protein, supplied broad and durable immunity for the prevention of infection. The speaker questions why the vaccine wasn't changed to target the nucleoprotein once this information came to light.

先生方のプロフィールを紹介します。コマ野先生は薬学博士であり、100年生き方塾の代表理事を務めています。最近の研究では、コロナワクチン接種後に認知症リスクが増加することが示されました。65歳以上の人々に対する55万人の調査では、ワクチン接種者の認知症リスクが未接種者に比べて2倍増加しました。この結果は深刻であり、認知症の増加は重要な問題です。 Translation: Let me introduce the profiles of our guest speakers. Dr. Komanoya, a pharmaceutical doctor and representative director of the 100-Year Living Institute, discussed recent research showing an increased risk of dementia after receiving the corona vaccine. In a study of 550,000 people aged 65 and older, the risk of dementia for vaccine recipients doubled compared to non-recipients. This finding is concerning, highlighting the significant issue of dementia increase.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then trigger an immune response. The vaccine components are said to break down and disappear from the body within days, leaving no trace and unable to affect DNA. However, some claim that data from the Therapeutic Goods Administration in Australia shows the vaccine distributes throughout the body, not just the injection site, and that there was no data on how quickly it degrades. Research indicates vaccine mRNA can be detected in some individuals for up to 14-15 days. A rare post-vaccination syndrome (PVS) is described where individuals exhibit elevated levels of spike protein for extended periods, up to 709 days, along with reactivation of dormant viruses. A hypothesis suggests that in some individuals, the vaccine mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T-cell exhaustion. The concern is raised about the long-term health consequences and potential for germline transfer if DNA is altered.

Speaker 0 describes what he claims is the strongest case report ever done on vaccine injury, specifically mRNA vaccine injury. The subject is a 51-year-old man who developed myocarditis, pulmonary embolism, neurological disturbances, and skin disturbances, constituting multisystem long vaccine syndrome. The key findings are said to be detected 3.6 years after his last shot. Exosomes circulating in his body allegedly contain Pfizer mRNA, and this mRNA is still present in those exosomes years after vaccination. The same mRNA is reportedly also found in his skin. In addition, plasmid DNA from the manufacturing process is claimed to be present in his skin, again 3.6 years after vaccination. Specifically, the plasmid DNA allegedly includes the SV40 segment, the spike expression cassette, and the open reading frame region, with all components of the plasmids in the Grover's disease–affected skin area. Microscopic analysis of the Grover’s disease area allegedly showed staining for SARS-CoV-2 spike or vaccine spike, indicating the presence of spike protein in that skin region. This staining for spike protein is reported as occurring 3.6 years after the shot. Overall, the speaker asserts that all vaccine components—mRNA, plasmid DNA with defined segments, and spike protein—remain in the body for multiple years, with findings in exosomes and skin indicating long-lasting presence. The speaker also asserts that this represents a situation in which “we were completely lied to.”

The spike protein produced by the COVID-19 vaccine is found not only in the deltoid muscles where it is injected, but also in various organs. In a case study of a 28-year-old man who died 140 days after vaccination, the spike protein was strongly expressed in the testes, leading to a decrease in spermatocytes. Similar findings were observed in an older man. The speaker personally finds these findings disturbing and suggests that women of childbearing age should avoid planning motherhood with vaccinated men.

私は、司法解剖で薬害を受けた人々についての意見書を出すことを隠蔽したくない。ワクチンによるパンデミック解決は妄想であり、メッセージRNAの危険性が明らかになってきた。ワクチン接種後に体調不良を訴える人は医療機関に報告すべきであり、自然免疫が抑えられることによって問題が広がっている。現在、多くの人が感染しており、ワクチン接種者同士の感染も起きている。厚労省のデータは明らかであり、この問題についてさらに話し合う必要がある。 I believe we should not hide the fact that we are issuing opinions on those who have been affected by drug harm through judicial autopsies. The idea that the pandemic will be resolved by the vaccine is a delusion, and the danger of messenger RNA has become clear. People who feel unwell after vaccination should report to medical institutions, as the suppression of natural immunity has led to the current situation. Many people are currently infected, including vaccinated individuals infecting each other. The data provided by the Ministry of Health, Labour and Welfare is clear, and further discussion on this issue is necessary.

There's new evidence suggesting shedding might be real. The mRNA vaccines were called vaccines instead of gene therapy so they wouldn't have to test for shedding on non-injected people. We're giving your body the code to make the virus' spike protein, creating immunity. The spike protein alone won't kill you, but your body learns to eliminate it. If you later get COVID, your body will recognize and attack the spike protein. However, there's no guarantee your body stops producing the spike protein. Your cells, once healthy, now make spike proteins, which your immune system attacks, even if it's your own cells. The mRNA in the vaccines is stabilized to last longer and is coated in lipid nanoparticles to protect it and cross the blood-brain barrier.

The spike protein from the COVID-19 virus circulates in the body and can land in multiple organs, causing various diseases. Lab studies have shown that even without the virus, just injecting the spike protein can induce the same lung, vascular, heart, and brain diseases as COVID-19. The spike protein is considered the toxin responsible for causing the disease. This raises questions about why we are injecting something that is essentially a toxin into the human body, as it is not a traditional vaccine.

Dr. Yeason presents three principal assertions about the vaccines. 1) The first principle: we were told these molecules were gene sequences that encoded something called the spike protein. The spike protein is described as on the outside of the virus, and vaccines were said to encode the protein to train the immune system. Dr. Yeason explains that the immune system treats anything foreign as a threat and will attack cells that manufacture a foreign protein, leading to tissue damage. He notes that this principle of “self, non self” and tissue targeting is fundamental to organ transplantation and autoimmune diseases, and says this was designed into every company’s molecule (Moderna, Pfizer, Johnson & Johnson, AstraZeneca). He asserts that by 2020 he knew these were designed to cause injury. 2) The second principle: what was encoded is the spike protein. He states he did not know what spike protein was at first, but describes spikes on the outside of the virus and claims they are known toxins (neurotoxins, cardiotoxins) that prompt blood coagulation. He questions why a medicinal product would encode something that would harm the body when expressed. 3) The third principle: lipid nanoparticles (LNPs) used to formulate two of the Pfizer and Moderna products. He explains that lipid nanoparticles are toxic in general and are known to promote uptake of their payload into visceral organs, especially the liver and ovaries. He asserts that when injected into women and girls, these materials would travel through the body, concentrate in reproductive organs, be expressed, be recognized as foreign, and kill those cells. He asks what possible motivation there could be for using that formulation when other options exist. This, he says, confirms that the first two observations were not mere risks but intentional design. Dr. Yeason concludes that these three points together indicate that someone in a room designed injections to injure, kill, and reduce fertility in the people given them, aiming to lower fertility and reduce the population over time. He states he has observed this “all around me for five years since that moment.”

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then triggers an immune response. The vaccine and spike protein are said to break down and disappear within days, leaving no trace and not affecting DNA. The vaccine is taken up at the injection site and quickly metabolized. However, an Australian Therapeutic Goods Administration document indicates the vaccine distributes throughout the body, including adipose tissue, adrenal glands, and the brain. There was allegedly no data on how quickly the mRNA degrades. Research indicates vaccine mRNA can be detected up to 14-15 days post-vaccination in some individuals. A rare post-vaccination syndrome (PVS) is associated with chronic conditions and elevated spike protein levels up to 709 days post-vaccination, even without detectable SARS-CoV-2 infection. One hypothesis suggests that the mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T cell exhaustion. The possibility of germline transfer and long-term health consequences is raised.

A peer-reviewed study by scientists in Japan and South Korea cultured COVID vaccines (mainly Pfizer and Moderna) and observed the development of nanostructures using stereo microscopes. Initially, 2D nanostructures formed, later becoming 3D. Observed structures included spirals and other formations, some as large as 10 micrometers, that spontaneously assembled. The researchers suggest these findings indicate the presence of nanotechnology in the injectables and warrant explanation from manufacturers and authorizing agencies. The study documented real-time injuries at the cellular level in recipients. The analysis revealed 3 to 4 million self-assembling entities per milliliter, ranging from 1 to 100 micrometers, including worm-like entities, discs, chains, spirals, tubes, and right-angled structures. Incubation studies showed simple structures evolving into complex 3D entities over 2-3 weeks, resembling carbon nanotube filaments and beaded chains. The researchers infer a potential pathophysiological mechanism for adverse reactions and call for further research. The study was published in the International Journal of Vaccine Theory, Practice, and Research.

新型コロナワクチンの接種は2021年から始まり、日本では4億回以上の接種が行われています。接種率は80％で、副反応報告は3万6千件を超えています。一部の接種後に重篤な症状が現れており、死亡疑い報告も2168件あります。国は重大な懸念を示しており、接種後の死亡が増えるとさらなる検討が必要です。 Translation: The vaccination of the new coronavirus began in 2021, with over 400 million doses administered in Japan. The vaccination rate is 80%, with over 36,000 reported adverse reactions. Some individuals experienced severe symptoms after vaccination, and there have been 2,168 reports of suspected deaths. The country is expressing serious concerns, and further consideration is needed as the number of deaths post-vaccination increases.

6月15日現在、1800万人の接種回数分のデータが蓄積されている。接種者と非接種者を比較すると、非接種者はフラットだが、接種者は1ヶ月後から3～4ヶ月にかけて死亡者の山ができる。 医師たちは接種当日、翌日、1週間ぐらいに発生した副作用をPMDAに送る。接種を重ねるほど、死亡者の山が左に移動する現象が確認された。つまり、打てば打つほど死亡時期が早まる。 ワクチン接種に毒性や死亡を誘導する効果がなければ、この山はできない。接種回数が増えるほど山が左に移動するのは、毒素が蓄積し、回数が増えるほど早く死亡することを意味すると思われる。 **Translation:** As of June 15th, data has been accumulated for 18 million vaccinations. Comparing vaccinated and unvaccinated individuals, the unvaccinated remain flat, but the vaccinated show a peak in deaths from one month to three to four months after vaccination. Doctors send reports of side effects occurring on the day of vaccination, the next day, and within about a week to the PMDA. It was confirmed that as vaccinations increase, the peak of deaths shifts to the left. In other words, the more shots, the earlier the death. If the vaccination did not have toxic or death-inducing effects, this peak would not exist. The more the number of vaccinations increases, the more the peak shifts to the left, which seems to mean that toxins accumulate, and the more the number of vaccinations, the faster death occurs.

専門家は、2021年以降、モデルナやファイザーのワクチンについて決戦ができると述べています。日本では報道されなかったが、新型コロナワクチンの後遺症が他のワクチンよりも多く報告されています。死者数が増加しており、問題となっています。 Translation: Experts say that a battle can be fought with the Moderna and Pfizer vaccines since 2021. In Japan, it was not reported, but the side effects of the new coronavirus vaccine have been reported more than other vaccines. The number of deaths is increasing and has become a problem.

**Original Language (Japanese):** 市町村が持っているワクチン接種データを解析した結果、接種後120日前後に死亡者の大きなピークがあることが判明。ワクチンが死亡を誘導しないなら、このようなピークはありえない。接種後数ヶ月経ってから死亡する人が多いため、ワクチン接種による死亡が実際より少なく計上されている可能性がある。接種回数が増えるごとに、死亡までの時間が短くなる傾向が見られる。mRNAワクチンには免疫抑制作用があり、スパイクタンパク質の産生量に比例する。スパイクタンパク質を発現する細胞が免疫によって破壊されることも毒性の可能性がある。ワクチン接種の死亡者数は想像以上に多く、毎年の超過死亡の原因の一つかもしれない。約7万人の仲間とともにmRNAワクチン接種を止めさせるよう政府に働きかけているが、まだ成功していない。先週、ワクチン接種を止めるべきだという署名約10万人以上を厚生労働省に提出。国際的に協力し、危険なワクチン接種を止めさせるよう頑張りたい。 **English Translation:** Analysis of municipal vaccination data revealed a significant peak in deaths around 120 days post-vaccination. Such a peak would be impossible if the vaccine did not induce mortality. Because many deaths occur months after vaccination, vaccine-related deaths may be underreported. The time to death tends to decrease with each subsequent dose. mRNA vaccines have an immunosuppressive effect proportional to spike protein production. The destruction of spike protein-expressing cells by the immune system is another potential toxicity. The number of vaccine-related deaths may be higher than imagined, potentially contributing to annual excess mortality. Along with approximately 70,000 colleagues, efforts are underway to stop mRNA vaccinations, but have not yet succeeded. Last week, a petition with over 100,000 signatures to halt vaccinations was submitted to the Ministry of Health, Labour and Welfare. There is a desire to collaborate internationally to stop dangerous vaccinations.

The speaker presents findings that indicate the spike protein from the COVID-19 vaccine is produced not only in the deltoid muscles but also in various organs. They show images of the testes in a 28-year-old man who died 140 days after vaccination, revealing strong expression of the spike protein in the spermatogenic organ. Similar results are observed in an older man. The speaker concludes by expressing personal concern about the implications of these images.